CRISPR-Cas System: A Brief History and Future in the Diagnosis and Treatment of Infectious Diseases

被引：0
|
作者：
Otlu, Baris [1 ]
机构：
[1] Inonu Univ, Dept Med Microbiol, Sch Med, Malatya, Turkey
来源：
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY | 2019年 / 1卷 / 01期
关键词：
DNA; REPEATS; RNA; SEQUENCE; TARGET;
D O I：
10.5152/idcm.2019.19007
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：2 / 5
页数：4
相关论文
共 50 条
  • [31] Lamarckian realities: the CRISPR-Cas system and beyond
    Jablonka, Eva
    BIOLOGY & PHILOSOPHY, 2019, 34 (01)
  • [32] Crispr-Cas, The Prokaryotic Adaptive Immune System
    Marraffini, Luciano
    FASEB JOURNAL, 2016, 30
  • [33] The Impact of CRISPR-Cas System on Antiviral Therapy
    Bayat, Hadi
    Naderi, Fatemeh
    Khan, Amjad Hayat
    Memarnejadian, Arash
    Rahimpour, Azam
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (04) : 591 - 597
  • [34] The Phylogenetic Study of the CRISPR-Cas System in Enterobacteriaceae
    Kushwaha, Simran Krishnakant
    Kumar, Aryahi A.
    Gupta, Hardik
    Marathe, Sandhya Amol
    CURRENT MICROBIOLOGY, 2023, 80 (06)
  • [35] The CRISPR-Cas system: beyond genome editing
    Moineau, Sylvain
    Croteau, Felix R.
    Rousseau, Genevieve M.
    M S-MEDECINE SCIENCES, 2018, 34 (10): : 813 - 819
  • [36] CRISPR-Cas system for biomedical diagnostic platforms
    Wang, Zhen
    Cui, Wenguo
    VIEW, 2020, 1 (03)
  • [37] CRISPR-Cas System for RNA Detection and Imaging
    Siyu Chen
    Rujia Wang
    Chunyang Lei
    Zhou Nie
    Chemical Research in Chinese Universities, 2020, 36 : 157 - 163
  • [38] A hypothesis: CRISPR-Cas as a minimal cognitive system
    Yakura, Hidetaka
    ADAPTIVE BEHAVIOR, 2019, 27 (03) : 167 - 173
  • [39] History, evolution and classification of CRISPR-Cas associated systems
    Agarwal, Nisheeth
    Gupta, Radhika
    REPROGRAMMING THE GENOME: APPLICATIONS OF CRISPR-CAS IN NON-MAMMALIAN SYSTEMS, PT A, 2021, 179 : 11 - 76
  • [40] Applications of CRISPR-Cas System in Tumor Biology
    Ma, Mengdan
    Liu, Yuchen
    Huang, Weiren
    ONCOLOGIE, 2021, 23 (04) : 463 - 492
12345